© Getty Images

Layoffs as Sage Therapeutics reshuffles CNS pipeline

By Jonathan Smith

Less than a month after the U.S. Food and Drug Administration (FDA) gave its antidepressant drug zuranolone (Zurzuvae) a mixed welcome, Sage Therapeutics has launched plans to reorganize its operations by refocusing its drug development efforts and laying...

(Image: Getty/Kirtchanut)

New clinical trial firm formed following 3-company merger

By Melissa Fassbender

Three organizations have merged to form Apex Innovative Sciences, an independent clinical trial site operator focused on Phase I-IV studies for central nervous system indications and other therapeutic areas, including neurology, psychiatry, addiction,...


Follow us


View more


Featured Suppliers